Issue 107

emerging innovations

Psychedelic medicine to be worth US$5 billion by 2028

Tomorrow, Thursday, 17 November, industry leaders will meet in London for Emerging Innovations in Psychedelic Healthcare, to evaluate milestones in the commercialisation of psychedelic medicine.

The invite-only event, taking place at Sea Containers in South Bank, coincides with the release of The Psychedelics as Medicine Report: Fourth Edition.

The industry’s leading data and insights publication features contributions from researchers, regulators, lawyers and politicians, with thought leaders analysing the sector’s socioeconomic potential.

REGISTER YOUR INTEREST FOR TOMORROW'S EVENT
Natural Medicine Health Act

COLORADO DECRIMINALISES PSYCHEDELIC MEDICINE

In Colorado, adults over 21 will also be able to access psilocybin without a diagnosis, prescription or referral.

Read More

EUROPE'S MENTAL HEALTH CRISIS IN DATA

The use of antidepressants in the UK has skyrocketed 256% since 2000, with more effective treatments desperately needed.

Read More

BUSINESS AND INVESTMENT

atai Life Sciences reports Q3 2022 financial results.

Filament Health Q3 2022 financial results.

Psychedelic healthcare as a catalyst for change.

Anecdotal benefits of microdosing psychedelic medicines.

Beckley Psytech completes Phase I trial with 5-MeO-DMT formulation.

SCIENCE AND RESEARCH

Psilocybin in the treatment of fibromyalgia.

Mental health epidemic is shrinking UK workforce.

Following the success of the SOLD OUT PSYCH Symposium in 2022, the industry leading conference will return on Thursday 6 July 2023.

Super Early Bird tickets now on sale for £250 + VAT.

TICKET REGISTRATION

REGULATION AND LEGISLATION

It is time to end the war on drugs.

Majority of Oregon counties vote against psilocybin therapy.

Lawmaker in Evanston, Illinois sponsors decriminalisation bill.

Toronto psilocybin dispensary raided by police.

ARTICLES OF INTEREST

Mental health may be biggest factor in homicides.

Cost-of-living crisis causing strain on mental health.